Fixed cell-based assays for autoantibody detection in myasthenia gravis: a diagnostic breakthrough.
作者信息
Budhram Adrian
机构信息
Department of Clinical Neurological Sciences, Western University, London Health Sciences Centre, London, Ontario, Canada.
Department of Pathology and Laboratory Medicine, Western University, London Health Sciences Centre, London, Ontario, Canada.
出版信息
Lancet Reg Health West Pac. 2023 Aug 9;38:100876. doi: 10.1016/j.lanwpc.2023.100876. eCollection 2023 Sep.
Abstract
摘要
相似文献
1
Fixed cell-based assays for autoantibody detection in myasthenia gravis: a diagnostic breakthrough.用于重症肌无力自身抗体检测的固定细胞检测法：一项诊断突破。
Lancet Reg Health West Pac. 2023 Aug 9;38:100876. doi: 10.1016/j.lanwpc.2023.100876. eCollection 2023 Sep.
2
Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal.自身抗体水平作为重症肌无力患者管理生物标志物的作用：一项系统评价与专家评估
Eur J Neurol. 2023 Jan;30(1):266-282. doi: 10.1111/ene.15565. Epub 2022 Oct 7.
3
Myasthenia gravis: from autoantibodies to therapy.重症肌无力：从自身抗体到治疗。
Curr Opin Neurol. 2018 Oct;31(5):517-525. doi: 10.1097/WCO.0000000000000596.
4
Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis.基于细胞的方法与酶联免疫吸附法检测中国青少年重症肌无力乙酰胆碱受体抗体。
Pediatr Neurol. 2019 Sep;98:74-79. doi: 10.1016/j.pediatrneurol.2019.01.016. Epub 2019 Jan 30.
5
Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis.在传统抗体检测的三联阴性重症肌无力中，通过活细胞检测方法检测自身抗体。
Neuromuscul Disord. 2023 Feb;33(2):139-144. doi: 10.1016/j.nmd.2023.01.002. Epub 2023 Jan 6.
6
7
Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases.在重症肌无力和其他抗体介导疾病中使用基于细胞的检测方法。
Exp Neurol. 2015 Aug;270:66-71. doi: 10.1016/j.expneurol.2015.01.011. Epub 2015 Mar 14.
8
Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.重症肌无力中的自身抗体特异性；对改进诊断和治疗的意义。
Front Immunol. 2020 Feb 14;11:212. doi: 10.3389/fimmu.2020.00212. eCollection 2020.
9
Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status.针对广义自身免疫性重症肌无力中 B 细胞及下游效应物的治疗方法：现状。
Drugs. 2019 Mar;79(4):353-364. doi: 10.1007/s40265-019-1065-0.
10
Myasthenia gravis and the neuromuscular junction.重症肌无力与神经肌肉接头
Curr Opin Neurol. 2013 Oct;26(5):459-65. doi: 10.1097/WCO.0b013e328364c079.
引用本文的文献
1
Detection of Autoantibodies Against the Acetylcholine Receptor, Evaluation of Commercially Available Methodologies: Fixed Cell-Based Assay, Radioimmunoprecipitation Assay and Enzyme-Linked Immunosorbent Assay1.抗乙酰胆碱受体自身抗体的检测：市售方法的评估——基于固定细胞的检测法、放射免疫沉淀法和酶联免疫吸附测定法1
J Neuromuscul Dis. 2024;11(3):613-623. doi: 10.3233/JND-230210.
2
Pathophysiology of Childhood-Onset Myasthenia: Abnormalities of Neuromuscular Junction and Autoimmunity and Its Background.儿童期重症肌无力的病理生理学：神经肌肉接头异常、自身免疫及其背景
Pathophysiology. 2023 Dec 2;30(4):599-617. doi: 10.3390/pathophysiology30040043.
本文引用的文献
1
A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study.一项比较自身抗体诊断检测在重症肌无力中准确性的多中心、前瞻性、双盲研究：SCREAM研究
Lancet Reg Health West Pac. 2023 Jul 19;38:100846. doi: 10.1016/j.lanwpc.2023.100846. eCollection 2023 Sep.
2
Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis.在传统抗体检测的三联阴性重症肌无力中，通过活细胞检测方法检测自身抗体。
Neuromuscul Disord. 2023 Feb;33(2):139-144. doi: 10.1016/j.nmd.2023.01.002. Epub 2023 Jan 6.
3
Autoimmune Encephalitis Misdiagnosis in Adults.自身免疫性脑炎在成人中的误诊。
JAMA Neurol. 2023 Jan 1;80(1):30-39. doi: 10.1001/jamaneurol.2022.4251.
4
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis.固定细胞和活细胞检测在重症肌无力乙酰胆碱受体和肌肉特异性激酶抗体检测中的比较。
Neurol Neuroimmunol Neuroinflamm. 2022 Oct 21;10(1). doi: 10.1212/NXI.0000000000200038. Print 2023 Jan.
5
Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis.基于细胞的检测方法在血清阴性重症肌无力特征分析中的临床价值。
J Neurol Neurosurg Psychiatry. 2022 Sep;93(9):995-1000. doi: 10.1136/jnnp-2022-329284. Epub 2022 Jul 14.
6
Comparison of fixed cell-based assay to radioimmunoprecipitation assay for acetylcholine receptor antibody detection in myasthenia gravis.比较固定细胞基础测定法与放射免疫沉淀法检测重症肌无力乙酰胆碱受体抗体。
J Neurol Sci. 2022 Jan 15;432:120084. doi: 10.1016/j.jns.2021.120084. Epub 2021 Dec 8.
7
Improving laboratory diagnostics in myasthenia gravis.提高重症肌无力的实验室诊断水平。
Expert Rev Mol Diagn. 2021 Jun;21(6):579-590. doi: 10.1080/14737159.2021.1927715. Epub 2021 May 19.
8
Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.重症肌无力中的自身抗体特异性；对改进诊断和治疗的意义。
Front Immunol. 2020 Feb 14;11:212. doi: 10.3389/fimmu.2020.00212. eCollection 2020.
9
Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.乙酰胆碱受体抗体簇在血清阴性重症肌无力诊断中的临床特征和诊断价值。
JAMA Neurol. 2015 Jun;72(6):642-9. doi: 10.1001/jamaneurol.2015.0203.
Zotero 插件